Acquisition further strengthens specialty medicines and respiratory pipeline with camlipixant, a highly selective P2X3 antagonist and potential best-in-class treatment for refractory chronic cough
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Channel 4 is set to mark the Coronation in its trademark alternative fashion, with shows from Two Rivers, Noho and a new two-part documentary from Candle True Stories and Bitachon365.
Brexafemme complements GSK’s industry-leading infectious disease portfolio with an FDA approved treatment for vulvovaginal candidiasisSCYNEXIS will receive an upfront payment of $90 million with. | March 30, 2023
Investegate |GSK PLC Announcements | GSK PLC: Statement: Zantac (ranitidine) litigation investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.